KR20010079695A - 시클릭 프로사포신 유래 펩티드 및 그의 이용 - Google Patents
시클릭 프로사포신 유래 펩티드 및 그의 이용 Download PDFInfo
- Publication number
- KR20010079695A KR20010079695A KR1020017002478A KR20017002478A KR20010079695A KR 20010079695 A KR20010079695 A KR 20010079695A KR 1020017002478 A KR1020017002478 A KR 1020017002478A KR 20017002478 A KR20017002478 A KR 20017002478A KR 20010079695 A KR20010079695 A KR 20010079695A
- Authority
- KR
- South Korea
- Prior art keywords
- amino acid
- peptide
- acid
- hydrophobic amino
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9835998P | 1998-08-28 | 1998-08-28 | |
| US60/098,359 | 1998-08-28 | ||
| PCT/US1999/019378 WO2000012553A1 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010079695A true KR20010079695A (ko) | 2001-08-22 |
Family
ID=22268937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020017002478A KR20010079695A (ko) | 1998-08-28 | 1999-08-20 | 시클릭 프로사포신 유래 펩티드 및 그의 이용 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1105420A1 (hu) |
| JP (2) | JP4528443B2 (hu) |
| KR (1) | KR20010079695A (hu) |
| CN (1) | CN1324367A (hu) |
| AU (1) | AU751034B2 (hu) |
| BR (1) | BR9913490A (hu) |
| CA (1) | CA2341810A1 (hu) |
| CZ (1) | CZ2001655A3 (hu) |
| HU (1) | HUP0103265A3 (hu) |
| IL (1) | IL141586A0 (hu) |
| PL (1) | PL204359B1 (hu) |
| WO (1) | WO2000012553A1 (hu) |
| ZA (1) | ZA200102489B (hu) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| CA2341810A1 (en) * | 1998-08-28 | 2000-03-09 | Myelos Corporation | Cyclic prosaposin-derived peptides and uses thereof |
| AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
| IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
| CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
| WO2007127439A2 (en) | 2006-04-28 | 2007-11-08 | Children's Hospital Medical Center | Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
| CN101541307A (zh) * | 2006-10-20 | 2009-09-23 | 儿童医院医疗中心 | 自发形成的椭圆体磷脂单层囊泡 |
| CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
| EP3285735B1 (en) | 2015-04-23 | 2021-06-23 | The Procter & Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
| EP3423031B1 (en) | 2016-03-03 | 2021-09-08 | The Procter & Gamble Company | Aerosol antidandruff composition |
| CN109843252A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 指定毛发体积有益效果的浓缩型洗发剂泡沫剂型 |
| US10888505B2 (en) | 2016-10-21 | 2021-01-12 | The Procter And Gamble Company | Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space |
| EP3528894A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
| CN109862944A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型 |
| EP3528898A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam designating hair conditioning benefits |
| CN109789076A (zh) | 2016-10-21 | 2019-05-21 | 宝洁公司 | 具有低粘度和粘度降低剂的稳定致密洗发剂产品 |
| CN109843381A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 用于提供毛发护理有益效果的浓缩型洗发剂泡沫剂型 |
| US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
| US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
| US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
| CN111201010A (zh) | 2017-10-10 | 2020-05-26 | 宝洁公司 | 用呈泡沫形式的个人护理组合物处理毛发或皮肤的方法 |
| EP4400092A3 (en) | 2017-10-10 | 2024-10-16 | The Procter & Gamble Company | Compact shampoo composition with amino acid based anionic surfactants and cationic polymers |
| US11116703B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
| JP2020536885A (ja) | 2017-10-10 | 2020-12-17 | ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ | 無機塩低含有の、サルフェートを含まないパーソナルクレンジング組成物 |
| MX2020005900A (es) | 2017-12-20 | 2022-03-31 | Procter & Gamble | Composicion de champu clara que contiene polimeros de silicona. |
| US11318073B2 (en) | 2018-06-29 | 2022-05-03 | The Procter And Gamble Company | Low surfactant aerosol antidandruff composition |
| WO2021113583A1 (en) | 2019-12-06 | 2021-06-10 | The Procter & Gamble Company | Sulfate free composition with enhanced deposition of scalp active |
| WO2021173203A1 (en) | 2020-02-27 | 2021-09-02 | The Procter & Gamble Company | Anti-dandruff compositions with sulfur having enhanced efficacy and aesthetics |
| CN116568263A (zh) | 2020-12-04 | 2023-08-08 | 宝洁公司 | 包含恶臭减少材料的毛发护理组合物 |
| US20220378684A1 (en) | 2021-05-14 | 2022-12-01 | The Procter & Gamble Company | Shampoo Compositions Containing a Sulfate-Free Surfactant System and Sclerotium Gum Thickener |
| US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| CA2341810A1 (en) * | 1998-08-28 | 2000-03-09 | Myelos Corporation | Cyclic prosaposin-derived peptides and uses thereof |
-
1999
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Application Discontinuation
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Application Discontinuation
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1324367A (zh) | 2001-11-28 |
| IL141586A0 (en) | 2002-03-10 |
| HUP0103265A2 (hu) | 2002-02-28 |
| PL346346A1 (en) | 2002-02-11 |
| CA2341810A1 (en) | 2000-03-09 |
| HUP0103265A3 (en) | 2002-09-30 |
| JP2010150272A (ja) | 2010-07-08 |
| JP2002523518A (ja) | 2002-07-30 |
| EP1105420A1 (en) | 2001-06-13 |
| BR9913490A (pt) | 2001-09-25 |
| JP4528443B2 (ja) | 2010-08-18 |
| PL204359B1 (pl) | 2010-01-29 |
| AU751034B2 (en) | 2002-08-08 |
| CZ2001655A3 (cs) | 2001-11-14 |
| ZA200102489B (en) | 2002-06-04 |
| AU5690599A (en) | 2000-03-21 |
| WO2000012553A1 (en) | 2000-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4528443B2 (ja) | 環状プロサポシン由来のペプチドおよびその使用 | |
| CA2058443C (en) | Treating disorders by application of insulin-like growth factors and analogs | |
| DE69736712T2 (de) | Verfahren zur milderung von neuropatischen schmerz mit prosaposin verwandten peptiden | |
| US5703045A (en) | Treating disorders by application of insulin-like growth factors and analogs | |
| US6458357B1 (en) | Retro-inverso neurotrophic and analgesic peptides | |
| US6849602B1 (en) | Compositions for alleviating neuropathic pain with prosaposin receptor agonists | |
| WO1998039357A1 (en) | Method of alleviating neuropathic pain | |
| WO1998042746A2 (en) | Synthetic saposin c-derived neurotrophic peptides | |
| WO1998042746A9 (en) | Synthetic saposin c-derived neurotrophic peptides | |
| EP1183266A1 (en) | Retro-inverso peptides derived from leukemia inhibitory factor | |
| US7754690B2 (en) | Method of using retro inverso peptides derived from leukemia inhibitory factor | |
| MXPA01001966A (en) | Cyclic prosaposin-derived peptides and uses thereof | |
| US20020128193A1 (en) | Retro-inverso prosaposin-derived peptides and use thereof | |
| AU2002300005B2 (en) | Method of alleviating neuropathic pain | |
| AU4267297A (en) | Method of alleviating neuropathic pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |